Ten errors to avoid in managing type 2 diabetes: Getting back to the basics

Postgraduate Medicine

Volumn 104, Issue 2, 1998, Pages 35-43

  Trachtenbarg, David E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

2,4 THIAZOLIDINEDIONE DERIVATIVE; ACARBOSE; ALBUMIN; ALPHA GLUCOSIDASE INHIBITOR; BIGUANIDE DERIVATIVE; GLUCOSE; HEMOGLOBIN A1C; INSULIN; METFORMIN; ORAL ANTIDIABETIC AGENT; TROGLITAZONE;

ARTICLE; DIABETIC FOOT; DIABETIC NEPHROPATHY; DIABETIC NEUROPATHY; HOME MONITORING; HUMAN; IMPAIRED GLUCOSE TOLERANCE; NON INSULIN DEPENDENT DIABETES MELLITUS; ORAL DRUG ADMINISTRATION; PROTEINURIA;

EID: 0031869065     PISSN: 00325481     EISSN: None     Source Type: Journal    
DOI: 10.3810/pgm.1998.08.557     Document Type: Article

References (19)

1. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 1998;21(Suppl 1): S5-19
2. American Diabetes Association. Standards of medical care for patients with diabetes mellitus. Diabetes Care 1998; 21(Suppl 1):S23-31
3. International Diabetes Center. Staged diabetes management decisionpaths. Minneapolis: International Diabetes Center, Park Nicollet Medical Foundation, 1997
4. Abraira C, Colwell JA, Nuttall FQ, et al. Veterans Affairs Cooperative Study on glycemic control and complications in type II diabetes (VA CSDM): results of the feasibility trial. Veterans Affairs Cooperative Study in Type II Diabetes. Diabetes Care 1995;18(8):1113-23
5. Johnson JL, Wolf SL, Kabadi UM. Efficacy of insulin and sulfonylurea combination therapy in type II diabetes: a meta-analysis of the randomized placebo-controlled trials. Arch Intern Med 1996; 156(3):259-64
6. Peters AL, Davidson MB. Insulin plus a sulfonylurea agent for treating type 2 diabetes. Ann Intern Med 1991;115(1):45-53
7. Golay A, Guillet-Dauphine N, Fendel A, et al. The insulin-sparing effect of metformin in insulin-treated diabetic patients. Diabetes Metab Rev 1995;11(Suppl 1):S63-7
8. Troglitazone for non-insulin-dependent diabetes mellitus. Med Lett Drugs Ther 1997;39(1001):49-51
9. Coniff RF, Shapiro JA, Seaton TB, et al. A double-blind placebo-controlled trial evaluating the safety and efficacy of acarbose for the treatment of patients with insulin-requiring type II diabetes. Diabetes Care 1995;18(7):928-32
10. Faas A, Schellevis FG, Van Eijk JT. The efficacy of self-monitoring of blood glucose in NIDDM subjects: a criteria-based literature review. Diabetes Care 1997; 20(9):1482-6
11. Katz CM. How efficient is sliding-scale insulin therapy? Problems with a "cookbook" approach in hospitalized patients. Postgrad Med 1991;89(5):46-57
12. Queale WS, Seidler AJ, Brancati FL. Glycemic control and sliding scale insulin use in medical inpatients with diabetes mellitus. Arch Intern Med 1997;157(5):545-52
13. Fredrickson L, ed. The insulin pump therapy book: insights from the experts. Sylmar, Calif: MiniMed Technologies, 1995:50
14. Eli Lilly and Company. Dosing guidelines for patients starting on Humalog and Humulin N. (Pocket calculator card) 1997
15. Pratt-Gregory R, Davis DL. Use of carbohydrate counting for meal planning in type I diabetes. Diabetes Educ 1994; 20(5):406-9
16. Ohkubo Y, Kishikawa H, Araki E, et al. Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study. Diabetes Res Clin Pract 1995;28(2):103-17
17. American Diabetes Association. Diabetic retinopathy. Diabetes Care 1998; 21(Suppl 1):S47-9
18. American Diabetes Association. Diabetic nephropathy. Diabetes Care 1998; 21(Suppl 1):S50-3
19. American Diabetes Association. Foot care in patients with diabetes mellitus. Diabetes Care 1998;21(Suppl 1):S54-5